Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

251 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial.
de Fijter JW, Holdaas H, Øyen O, Sanders JS, Sundar S, Bemelman FJ, Sommerer C, Pascual J, Avihingsanon Y, Pongskul C, Oppenheimer F, Toselli L, Russ G, Wang Z, Lopez P, Kochuparampil J, Cruzado JM, van der Giet M; ELEVATE Study Group. de Fijter JW, et al. Among authors: bemelman fj. Am J Transplant. 2017 Jul;17(7):1853-1867. doi: 10.1111/ajt.14186. Epub 2017 Feb 14. Am J Transplant. 2017. PMID: 28027625 Free article. Clinical Trial.
No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
Rowshani AT, Scholten EM, Bemelman F, Eikmans M, Idu M, Roos-van Groningen MC, Surachno JS, Mallat MJ, Paul LC, de Fijter JW, Bajema IM, ten Berge I, Florquin S. Rowshani AT, et al. J Am Soc Nephrol. 2006 Jan;17(1):305-12. doi: 10.1681/ASN.2005030249. Epub 2005 Nov 23. J Am Soc Nephrol. 2006. PMID: 16306168 Clinical Trial.
Molecular comparison of calcineurin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies.
Roos-van Groningen MC, Scholten EM, Lelieveld PM, Rowshani AT, Baelde HJ, Bajema IM, Florquin S, Bemelman FJ, de Heer E, de Fijter JW, Bruijn JA, Eikmans M. Roos-van Groningen MC, et al. Among authors: bemelman fj. J Am Soc Nephrol. 2006 Mar;17(3):881-8. doi: 10.1681/ASN.2005080891. Epub 2006 Feb 8. J Am Soc Nephrol. 2006. PMID: 16467444 Clinical Trial.
Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
Scholten EM, Rowshani AT, Cremers S, Bemelman FJ, Eikmans M, van Kan E, Mallat MJ, Florquin S, Surachno J, ten Berge IJ, Bajema IM, de Fijter JW. Scholten EM, et al. Among authors: bemelman fj. J Am Soc Nephrol. 2006 Sep;17(9):2622-32. doi: 10.1681/ASN.2006030227. Epub 2006 Aug 9. J Am Soc Nephrol. 2006. PMID: 16899517 Clinical Trial.
Older living kidney donors: surgical outcome and quality of life.
Minnee RC, Bemelman WA, Polle SW, van Koperen PJ, Ter Meulen S, Donselaar-van der Pant KA, Bemelman FJ, Idu MM. Minnee RC, et al. Among authors: bemelman fj, bemelman wa. Transplantation. 2008 Jul 27;86(2):251-6. doi: 10.1097/TP.0b013e31817789dd. Transplantation. 2008. PMID: 18645487
Intragraft FOXP3 protein or mRNA during acute renal allograft rejection correlates with inflammation, fibrosis, and poor renal outcome.
Yapici U, Bemelman FJ, Scheepstra CG, Roelofs JJ, Claessen N, van der Loos C, van Donselaar-van der Pant K, Bouts AH, Idu MM, Rowshani AT, ten Berge IJ, Florquin S. Yapici U, et al. Among authors: bemelman fj. Transplantation. 2009 May 15;87(9):1377-80. doi: 10.1097/TP.0b013e3181a24a4b. Transplantation. 2009. PMID: 19424039
251 results